Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2014
09/02/2014US8821894 Compositions and methods related to protein A (SpA) variants
09/02/2014US8821893 Oral vaccine for Borrelia
09/02/2014US8821892 Yeast-based therapeutic for chronic hepatitis C infection
09/02/2014US8821891 Live attenuated rotavirus vaccine for oral administration
09/02/2014US8821890 Influenza virus vaccine composition and methods of use
09/02/2014US8821889 West Nile Virus vaccine
09/02/2014US8821887 T-cell antigen peptide from allergen for stimulation of IL-10 production
09/02/2014US8821886 Recombinant antigen
09/02/2014US8821885 Immunogenic compositions and methods
09/02/2014US8821884 Compositions and methods using MD-2 mutants and chimeric proteins
09/02/2014US8821883 Method of treating B cell cancers by administering truncated BAFF receptors
09/02/2014US8821882 Vaccine preparation for neospora caninum infection
09/02/2014US8821881 Quil A fraction with low toxicity and use thereof
09/02/2014US8821880 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
09/02/2014US8821879 Anti-botulism antibody coformulations
09/02/2014US8821878 Compositions of human lipids and methods of making and using same
09/02/2014US8821877 Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist
09/02/2014US8821876 Methods of identifying infectious disease and assays for identifying infectious disease
09/02/2014US8821875 Pharmaceutical composition comprising antibodies against catalase and superoxide dismutase for tumor therapy
09/02/2014US8821874 KLK-13 antibody inhibitor for treating dry eye
09/02/2014US8821873 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
09/02/2014US8821872 Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer
09/02/2014US8821871 Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof
09/02/2014US8821870 Method for treating atrophic age related macular degeneration
09/02/2014US8821869 Treatment methods using c-Met antibodies
09/02/2014US8821868 Anti-pancreatic cancer antibodies
09/02/2014US8821867 4-1BB binding molecules
09/02/2014US8821866 Methods of treating and preventing colitis involving IL-13 and NK-T cells
09/02/2014US8821865 High concentration anti-TNFα antibody liquid formulations
09/02/2014US8821864 Compounds and methods useful for detection and treatment of cancer
09/02/2014US8821863 Humanized anti-α 9 integrin antibodies and the uses thereof
09/02/2014US8821852 Vaccines with live bacterial isolates for systemic administration
09/02/2014CA2736974C Tumour-associated peptides that bind to mhc molecules
09/02/2014CA2594918C Dr5 antibodies and uses thereof
09/02/2014CA2466937C Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation processes and immunogene compositions containing such an antigen
09/02/2014CA2438315C Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom
09/02/2014CA2413866C Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
08/2014
08/28/2014WO2014131034A2 Antibodies to oxidized phospholipids
08/28/2014WO2014130938A1 Particle formulations for delivery of tlr agonists and antigens
08/28/2014WO2014130741A2 Nme inhibitors and methods of using nme inhibitors
08/28/2014WO2014130723A1 Methods and compositions for treatment of pompe disease
08/28/2014WO2014130722A1 Methods and compositions for treatment of forbes-cori disease
08/28/2014WO2014130655A2 Compositions and methods to inactivate and/or reduce production of microbial toxins
08/28/2014WO2014130635A1 Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
08/28/2014WO2014130617A1 Method of predicting breast cancer prognosis
08/28/2014WO2014130313A2 Methods and compositions relating to the treatment of cancer
08/28/2014WO2014128628A1 Cytoplasmic expression of fab proteins
08/28/2014WO2014128504A1 Inactive n-acetylated-alpha-linked acidic dipeptidase-like protein 2 (naaladl2) as a therapeutic and diagnostic target
08/28/2014WO2014128305A1 Vaccination strategy
08/28/2014WO2014128259A1 Pharmaceutical composition for the treatment of burnout syndrome
08/28/2014WO2014128258A1 Caix stratification based cancer treatment
08/28/2014WO2014128245A1 Dna hypomethylating agents for cancer therapy
08/28/2014WO2014128221A1 A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphoma
08/28/2014WO2014128185A1 Recombinant bispecific antibody that binds to the cd133 antigen on tumor cells and to the human cd3 t cell receptor
08/28/2014WO2014127917A1 Combination of vaccination and inhibition of the pd-1 pathway
08/28/2014WO2014127906A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
08/28/2014WO2014127825A1 H5 proteins of h5n1 influenza virus for use as a medicament
08/28/2014WO2014127785A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
08/28/2014WO2014127479A1 Inhibition of sema3a in the prevention and treatment of ocular hyperpermeability
08/28/2014WO2014127478A1 Vaccine composition
08/28/2014WO2014089335A3 Bcma antigen binding proteins
08/28/2014WO2014083060A3 Pseudomonas antigens and antigen combinations
08/28/2014WO2014075047A3 Malaria antigens and methods of use
08/28/2014WO2014009971A3 Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof
08/28/2014WO2012057877A3 Combinations of anti-s1p antibodies and sphingolipid pathway inhibitors
08/28/2014US20140242635 Fermentation Process for the Production of Diphtheria Toxin
08/28/2014US20140242173 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
08/28/2014US20140242152 Immunogenic compositions and uses thereof
08/28/2014US20140242117 Vaccine Composition Capable of Inducing Memory Antibody Response from Single Point Immunization
08/28/2014US20140242116 Spray Dried Compositions and Methods of Use
08/28/2014US20140242115 Inactivating pathogens with oxidizing agents for vaccine production
08/28/2014US20140242113 Liquid vaccine preparations
08/28/2014US20140242112 Novel vaccine
08/28/2014US20140242110 Dose, localization, and formulation of botulinum toxins in skin and muscle
08/28/2014US20140242107 Direct Protein Delivery with Engineered Microvesicles
08/28/2014US20140242106 Staphylococcus aureus proteins and nucleic acids
08/28/2014US20140242105 Vaccines for chlamydia
08/28/2014US20140242104 Self-assembling peptide nanoparticles as vaccines against infection with norovirus
08/28/2014US20140242103 Composition
08/28/2014US20140242102 Influenza hemagglutinin and neuraminidase variants
08/28/2014US20140242101 Pd-l1 based immunotherapy
08/28/2014US20140242094 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
08/28/2014US20140242089 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
08/28/2014US20140242086 Polynucleotides encoding signal peptide-containing molecules
08/28/2014US20140242082 Combination therapy for the treatment of ocular neovascular disorders
08/28/2014US20140242078 Methods and monitoring of treatment with a wnt pathway inhibitor
08/28/2014US20140242077 Methods and compositions for modulating an immune response
08/28/2014US20140242073 Cartilage/bone destruction suppressor
08/28/2014US20140242071 M-csf specific monoclonal antibody and uses thereof
08/28/2014US20140242069 KRT19 Stabilizing HER2 and Use thereof
08/28/2014US20140242067 Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
08/28/2014US20140242026 Compounds, compositions, and methods for preventing metastasis of cancer cells
08/28/2014US20140241983 Methods and Compositions for Enhancing the Therapeutic Effect of Anti-Tumor T Cells
08/27/2014EP2770061A1 Non-integrating lentiviral vectors
08/27/2014EP2769993A1 Antibodies against human NKG2D and uses thereof
08/27/2014EP2769992A2 High affinity human antibodies to human IL-4 receptor
08/27/2014EP2769990A2 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
08/27/2014EP2769737A1 Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
08/27/2014EP2769736A1 Pharmaceutical composition for the treatment of burnout syndrome
08/27/2014EP2769735A1 Refrigerator-temperature stable influenza vaccine compositions
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 1823